- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 834-848 of
973 results
2441 Exhibit: EX2441 Jardiance® Prescribing Information rev Dec 2016
Document
IPR2023-00724, No. 2441 Exhibit - EX2441 Jardiance® Prescribing Information rev Dec 2016 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
1099 Exhibit: Exhibit 1099 Garber 2011b
Document
IPR2023-00724, No. 1099 Exhibit - Exhibit 1099 Garber 2011b (P.T.A.B. May. 22, 2024)
|
|
Cite Document
1133 Exhibit: Exhibit 1133 37th Orange Book
Document
IPR2023-00724, No. 1133 Exhibit - Exhibit 1133 37th Orange Book (P.T.A.B. May. 22, 2024)
|
|
Cite Document
1100 Exhibit: Exhibit 1100 Jose
Document
IPR2023-00724, No. 1100 Exhibit - Exhibit 1100 Jose (P.T.A.B. May. 22, 2024)
|
|
Cite Document
2408 Exhibit: EX2408 US Food Drug Administration, DrugsFDA, Victoza®
Document
IPR2023-00724, No. 2408 Exhibit - EX2408 US Food Drug Administration, DrugsFDA, Victoza® (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2463 Exhibit: EX2463 US Food Drug Administration, DrugsFDA, Ozempic
Document
IPR2023-00724, No. 2463 Exhibit - EX2463 US Food Drug Administration, DrugsFDA, Ozempic (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2092 Exhibit: EX2092 Das, SR, et al, Expert Consensus Decision Pathway on Nove...
Document
IPR2023-00724, No. 2092 Exhibit - EX2092 Das, SR, et al, Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes, J Am Co...
|
|
Cite Document
2013 Exhibit: EX2013 Heerspink, H, et al, “Effects of Semaglutide on Albuminuria a...
Document
IPR2023-00724, No. 2013 Exhibit - EX2013 Heerspink, H, et al, “Effects of Semaglutide on Albuminuria and Kidney Function in People with Overweight or Obesity With or Without Type 2 Diabete...
|
|
Cite Document
2097 Exhibit: EX2097 García Casares, N, et al, Effects of GLP 1 receptor agonists ...
Document
IPR2023-00724, No. 2097 Exhibit - EX2097 García Casares, N, et al, Effects of GLP 1 receptor agonists on neurological complications of diabetes, Rev Endocr Metab Disord, 24655 672 2023 (P...
|
|
Cite Document
2061 Exhibit: EX2061 Nordqvist, C, “Experimental Diabetes Drug Taspoglutide Late...
Document
IPR2023-00724, No. 2061 Exhibit - EX2061 Nordqvist, C, “Experimental Diabetes Drug Taspoglutide Late Stage Trials Suspended,” available at httpswwwmedicalnewstodaycomarticles200893 S...
|
|
Cite Document
2494 Exhibit: EX2494 Novo Nordisk, Financial report for the period 1 January 2018...
Document
IPR2023-00724, No. 2494 Exhibit - EX2494 Novo Nordisk, Financial report for the period 1 January 2018 to 31 March 2018 May 2, 2018 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2388 Exhibit: EX2388 Cramer, JA, Medication compliance and persistence termino...
Document
IPR2023-00724, No. 2388 Exhibit - EX2388 Cramer, JA, Medication compliance and persistence terminology and definitions, Value Health 2008 Jan Feb 11144 47 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2465 Exhibit: EX2465 US Food Drug Administration, DrugsFDA, Steglatro
Document
IPR2023-00724, No. 2465 Exhibit - EX2465 US Food Drug Administration, DrugsFDA, Steglatro (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2086 Exhibit: EX2086 Abdul Ghani, M, et al, Cardiovascular Disease and Type 2 Di...
Document
IPR2023-00724, No. 2086 Exhibit - EX2086 Abdul Ghani, M, et al, Cardiovascular Disease and Type 2 Diabetes Has the Dawn of a New Era Arrived, Diabetes Care, 40813 820 2017 (P.T.A.B. Ja...
|
|
Cite Document
1300 Exhibit: Exhibit 1300 Bantle Decl
Document
IPR2023-00724, No. 1300 Exhibit - Exhibit 1300 Bantle Decl (P.T.A.B. May. 22, 2024)
|
|
Cite Document
